# A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee

> **NCT00944892** · PHASE1,PHASE2 · COMPLETED · sponsor: **Regeneron Pharmaceuticals** · enrollment: 200 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** REGN475
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00944892
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944892, "A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00944892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*